UNIVERSITY OF MICHIGAN NICOTINE RESEARCH LABORATORY
SCIENTIFIC PUBLICATIONS Dr. Ovide Pomerleau
Peer-Reviewed Papers in Scientific Journals 1. Ramsey DA, Pomerleau OF, Snapper AG (1968). Two methods for obtaining electrocardiograms of chair-restrained monkeys. Conditional Reflex 3:200-204. 2. Pomerleau OF (1969). A three-electrode system for EKG recording and aversive shock. Conditional Reflex 4:59-60. 3. Pomerleau OF, Snapper AG, Schoenfeld WN (1969). Perseveration of cardiac rate effects in the rhesus monkey following Pavlovian conditioning. Conditional Reflex 4:52-58. 4. Snapper AG, Pomerleau OF, Schoenfeld WN (1969). Similarity of cardiac CR form in the rhesus monkey under several experimental procedures. Conditional Reflex 4:212-220. 5. Pomerleau OF (1970). The effect of stimuli followed by response-independent shock on shock-avoidance behavior. Journal of Experimental Analysis of Behavior 14:11-21. 6. Pomerleau OF, Bobrove PH, Harris LC (1972). Some observations on a controlled social environment for psychiatric patients. Journal of Behavior Therapy and Experimental Psychiatry 3:15-21. 7. Pomerleau OF, Bobrove PH, Smith RH (1973). Rewarding psychiatric aides for the improvement of assigned patients. Journal of Applied Behavior Analysis 6:383-390; reprinted in Psychotherapy and Behavior Change Annual, H Strupp (Ed.). Chicago: Aldine Publishing Company. 8. Pomerleau OF, Bass F, Crown V (1975). The role of behavior modification in preventive medicine. New England Journal of Medicine 292(24):1277-1282. 9. Pomerleau OF, Pertschuk M, Stinnett J (1976). A critical examination of some current assumptions in the treatment of alcoholism. Journal of Studies on Alcohol, 37:849-867; reprinted in Interfaces between Alcoholism and Mental Health, E.X. Freed, (Ed.), Vol. 3. New Brunswick, NJ: Rutgers Center of Alcohol Studies. 10. Pomerleau OF, Adkins D, Pertschuk M (1978). Predictors of outcome and recidivism in smoking-cessation treatment. Addictive Behaviors 3:65-70. 11. Pomerleau OF, Pertschuk M, Adkins D, Brady JP (1978). A comparison of behavioral and traditional treatment for middle-income problem drinkers. Journal of Behavioral Medicine 1(2):187-200. 12. Pertschuk M, Edwards N, Pomerleau OF (1978). A multiple baseline approach to behavioral intervention in anorexia nervosa. Behavior Therapy 9:368-376. 13. Pomerleau OF (1979). Research priorities in alcohol studies: The role of psychology. Journal of Studies on Alcohol (special supplement on research priorities on alcohol studies--the role of the biological, psychological, and social sciences), November 8, 75-95. 14. Pertschuk M, Pomerleau OF, Adkins D, Hirsh C (1979). Smoking cessation: The psychological costs. Addictive Behaviors 4:345-348. 15. Pomerleau OF (1979). Behavioral medicine: The contribution of the experimental analysis of behavior to medical care. American Psychologist 34:654-663. 16. Pomerleau OF, Hall W (1980). Clinical behavioral medicine in a small general hospital. American Journal of Clinical Biofeedback 3:45- 47. 17. Pomerleau OF (1980). Limitations of current treatment on smoking: A discourse on the need to understand underlying mechanisms. Behavioral Medicine Update, February, 2(1):22-26. 18. Pomerleau OF (1981). Underlying mechanisms in substance abuse: Examples from research on smoking. Addictive Behaviors 6:187-196. 19. Pomerleau OF (1982). A discourse on behavioral medicine: Current status, future trends. Journal of Consulting and Clinical Psychology, 50(6):1030-1039. Reprinted in: R.O. Pihl (Ed.), Readings in Abnormal Psychology, (1984) (pp. 98-106). Lexington, MA: Ginn Custom Publishing. 20. Hill D, Brande W, Phillips D, Pomerleau OF (1983). A rapid, reliable plasma extraction method for nicotine gas chromatographic analysis. Analytical Letters, 16(B5): 355-365. 21. Pomerleau OF, Fertig JB, Baker L, Cooney N (1983). Reactivity to alcohol cues in alcoholics and non-alcoholics: Implications for a stimulus control analysis of drinking. Addictive Behaviors 8:1-10. 22. Pomerleau OF, Fertig JB, Seyler LE, Jaffe J (1983). Neuroendocrine reactivity to nicotine in smokers. Psychopharmacology 81:61-67. 23. Pomerleau OF, Fertig JB, Shanahan SO (1983). Nicotine dependence in cigarette smoking: An empirically-based, multivariate model. Pharmacology, Biochemistry, and Behavior 19:291-299. 24. Seyler LE, Fertig JB, Pomerleau OF, Hunt D, Parker K (1984). The effects of smoking on ACTH and cortisol secretion. Life Sciences 34:57-65. 25. Pomerleau OF, Turk DC, Fertig JB (1984). The effects of cigarette smoking on pain and anxiety. Addictive Behaviors 9:265-271. 26. Cooney NL, Baker LH, Pomerleau OF, Josephy B (1984). Salivation to drinking cues in alcohol abusers: Toward the validation of a physiological measure of craving. Addictive Behaviors 9:91-94. 27. Pomerleau OF, Pomerleau CS (1984). Neuroregulators and the reinforcement of smoking: Towards a biobehavioral explanation. Neuroscience and Biobehavioral Reviews, 8:503-513. 28. Kaplan RF, Cooney NL, Baker LH, Gillespie RA, Meyer RE, Pomerleau OF (1985). Reactivity to alcohol-related cues: Physiological and subjective responses in alcoholics and non-problem drinkers. Journal of Studies on Alcohol 46:267-272. 29. Seyler LE, Pomerleau OF, Fertig JB, Hunt D, Parker K (1986). Pituitary hormone response to cigarette smoking. Pharmacology Biochemistry & Behavior 24:159-162. 30. Fertig JB, Pomerleau OF, Sanders B (1986). Nicotine-produced antinociception in minimally deprived smokers and ex-smokers. Addictive Behaviors 11:239-248. 31. Pomerleau OF (1986). Nicotine as a psychoactive drug: Anxiety and pain reduction. Psychopharmacology Bulletin 22:863-883. 32. Pomerleau OF, Scherzer HH, Grunberg NE, Pomerleau CS, Judge J, Fertig JB, Burleson JE (1987). The effects of acute exercise on subsequent cigarette smoking. Journal of Behavioral Medicine 10:117-127. 33. Pomerleau CS, Pomerleau OF, Majchrzak MJ (1987). Mecamylamine pretreatment increases subsequent nicotine self-administration as indicated by changes in plasma nicotine level. Psychopharmacology 91:391-393. 34. Pomerleau CS, Pomerleau OF (1987). The effects of a psychological stressor on cigarette smoking and on subsequent behavioral and physiological responses. Psychophysiology 24:278-285. 35. Pomerleau OF, Pomerleau CS (1987). A biobehavioral view of substance abuse and addiction. Journal of Drug Issues, 17:111-131. Reprinted in: Peele S (Ed.), Visions of Addiction (pp. 117-139). Lexington, MA: Lexington Books. 36. Dolinsky ZS, Morse DE, Kaplan RF, Meyer RE, Corry D, Pomerleau OF (1987). Neuroendocrine, psychophysiological, and subjective reactivity to an alcohol placebo in male alcoholic patients. Alcoholism: Clinical and Experimental Research 11:296-300. 37. Pomerleau OF, Pomerleau CS (1989). Nicotine uses and abuses: From brain probe to public health menace. Journal of Substance Abuse 1:253-257. 38. Pomerleau OF, Pomerleau CS (1989). Stress, smoking, and the cardiovascular system. Journal of Substance Abuse 1:331-343. 39. Pomerleau CS, Majchrzak MJ, Pomerleau OF (1989). Nicotine dependence and the Fagerstrom Tolerance Questionnaire: A brief review. Journal of Substance Abuse 1:471-477. 40. Pomerleau CS, Majchrzak MJ, Pomerleau OF (1989). Paced puffing as a method for administering fixed doses of nicotine. Addictive Behaviors 14:571-575. 41. Pomerleau OF, Pomerleau CS, Rose JE (1989). Controlled dosing of nicotine: Problems and progress. Annals of Behavioral Medicine 11:158-163. 42. Pomerleau OF, Rosecrans J (1989). Neuroregulatory effects of nicotine. Psychoneuroendocrinology 14:407-423. 43. Pomerleau OF, Rose JE, Pomerleau CS, Majchrzak MJ (1989). A noninvasive method for delivering controlled doses of nicotine via cigarette smoke. Behavior Research Methods, Instruments, and Computers 21:598-602. 44. Pomerleau CS, Pomerleau OF, Majchrzak MJ, Kloska DD, Malakuti R (1990). Relationship between Nicotine Tolerance Questionnaire scores and plasma cotinine. Addictive Behaviors 15:73-80. 45. Morrell EM, Cameron OG, Kandarian SC, Renk CM, Weder AB, Pomerleau OF (1990). Aerobic physical training and alterations in pressor response during norepinephrine infusion: A controlled single-subject experiment. International Journal of Sports Medicine 11:53-57. 46. Pomerleau OF (1990). What does research on nicotine and tobacco use have to offer alcohol researchers? British Journal of Addiction 85:247-250. 47. Pomerleau OF, Pomerleau CS (1990). Cortisol response to a psychological stres-sor and/or nicotine. Pharmacology, Biochemistry & Behavior 36:211-213. 48. Pomerleau OF, Pomerleau CS (1990). Dexamethasone attenuation of the cortisol response to nicotine in smokers. Psychopharmacology 101:284-286. 49. Pomerleau CS, Pomerleau OF, McPhee K, Morrell EM (1990). Discordance of physiological and biochemical response to smoking and psychological stress. British Journal of Addiction 85:1309-1316. 50. Pomerleau CS, Pomerleau OF, Garcia AW (1991). Biobehavioral research on nicotine use in women. Invited article, special issue on "New Directions in Tobacco Research," British Journal of Addiction 86:527-531. 51. Pomerleau OF, Pomerleau CS (1991). Research on stress and smoking: Progress and problems. Invited article, special issue on "New Directions in Tobacco Research," in British Journal of Addiction 86:599-605. 52. Pomerleau OF, Pomerleau CS, Morrell EM, Lowenbergh JL (1991). Effects of fluoxetine upon weight gain and food intake in smokers who reduce nicotine intake. Psychoneuroendocrinology 16:433-440. 53. Pomerleau CS, Garcia AW, Drewnowski,A, Pomerleau OF (1991) Sweet taste preference in women smokers: Comparison with nonsmokers and effects of menstrual phase and nicotine abstinence. Pharmacology Biochemistry & Behavior 40:995-999. 54. Schramm W, Pomerleau OF, Pomerleau CS, Grates HE (1992). Cotinine in an ultrafiltrate of saliva. Preventive Medicine 21:63-73. 55. Pomerleau CS, Pomerleau OF, Flessland KA, Basson SM (1992). Relationship of Tridimensional Personality Questionnaire scores and smoking variables in female and male smokers. Journal of Substance Abuse 4:143-154. 56. Pomerleau CS, Pomerleau OF (1992). Euphoriant effects of nicotine in smokers. Psychopharmacology 108:460-465. 57. Pomerleau CS, Garcia AW, Pomerleau OF, Cameron OG (1992). The effects of menstrual phase and nicotine withdrawal on nicotine intake and on biochemical and subjective measures in women smokers: A preliminary report. Psychoneuroendocrinology 17:627-638. 58. Pomerleau OF, Flessland KA, Pomerleau CS, Hariharan M (1992). Controlled dosing of nicotine via Intra-nasal Nicotine Aerosol Delivery Device (INADD). Psychopharmacology 108:519-526. 59. Pomerleau OF, Hariharan M, Pomerleau CS, Cameron OG, Guthrie S (1993). Differences between smokers and never-smokers in sensitivity to nicotine; A preliminary report. Addiction (formerly British Journal of Addiction) 88: 113-118. 60. Pomerleau OF, Collins AC, Shiffman S, Pomerleau CS (1993). Why some people smoke and others do not: New perspectives. Journal of Clinical and Consulting Psychology, 61:723-731 61. Tate JC, Pomerleau OF, Pomerleau CS (1993). Temporal stability and within-subject consistency of nicotine withdrawal symptoms. Journal of Substance Abuse 5:355-363 62. Pomerleau CS, Ehrlich E, Tate JC, Marks JL, Flessland KA, Pomerleau OF (1993). The female weight-control smoker: A profile. Journal of Substance Abuse 5:391-400. 63. Tate JC, Pomerleau CS, Pomerleau OF (1994). Pharmacological and non-pharmacological smoking motives: A replication and extension. Addiction 89:341-350. 64. Pomerleau CS, Carton SM, Lutzke ML, Flessland KA, Pomerleau OF (1994). Reliability of the Fagerstrom Tolerance Questionnaire and the Fagerstrom Test for Nicotine Dependence. Addictive Behaviors 19:33-39. 65. Lumley MA, Downey K, Stettner L, Wehmer F, Pomerleau OF (1994) Alexithymia and negative affect: Relationship to cigarette smoking, nicotine dependence, and smoking cessation. Psychother Psychosom, 61:156-162. 66. Pomerleau CS, Cole PA, Lumley MA, Marks JL, Pomerleau OF (1994). Effects of menstrual phase on nicotine, alcohol, and caffeine intake in smokers. Journal of Substance Abuse 6:227-234. 67. Pomerleau CS, Teuscher F, Goeters S, Pomerleau OF (1994). Effects of nicotine abstinence and menstrual phase on task performance. Addictive Behaviors 19:357-362. 68. Fagerstrom K-O, Pomerleau OF, Giordani B, Stelson F (1994). Nicotine may relieve symptoms of Parkinson’s disease. Psychopharmacology 116:117-119. 69. Pomerleau CS, Tate JC, Lumley MA, Pomerleau OF (1994). Gender differences in prospectively- vs. retrospectively assessed smoking withdrawal symptoms. Journal of Substance Abuse 6:433-440. 70. Pomerleau OF, Pomerleau CS (1994). Euphoriant effects of nicotine. Tobacco Control 3:374. 71. Pomerleau OF (1995). Individual differences in sensitivity to nicotine: Implications for genetic research on nicotine dependence. Invited article, Behavioral Genetics 25:161-177. 72. Lumley MA, Schramm W, Pomerleau CS, Pomerleau OF, Smith RH (1995). The assessment of cortisol using salivary ultrafiltrate. Behavior Research Methods, Instruments, and Computers 27:470-475. 73. Pomerleau OF, Downey KK, Stelson FW, Pomerleau CS (1995). Cigarette smoking in adult patients diagnosed with Attention Deficit Hyperactivity Disorder. Journal of Substance Abuse 7:373-378. 74. Downey KK, Pomerleau CS, Pomerleau OF (1996). Personality differences related to smoking and adult Attention Deficit Hyperactivity Disorder. Journal of Substance Abuse 8:129-135. 75. Glover ED, Sachs DP, Stitzer ML, Rennard SI, Wadland WC, Pomerleau OF, Nowak RT, Daughton DM, Glover PN, Hughes JR, Gross J (1996). Smoking cessation in highly dependent smokers with 4 mg nicotine polacrilex. American Journal of Health Behavior 20:319-332. 76. Downey KK, Stelson FW, Pomerleau OF, Giordani B (1997). Adult Attention Deficit Hyperactivity Disorder: Psychological test profiles in a clinical population. Journal of Nervous and Mental Disease 185:32-38. 77. Pomerleau CS, Aubin H-J, Pomerleau OF (1997). Self-reported alcohol use patterns in a sample of male and female heavy smokers. Journal of Addictive Disease 16:19-24. 78. Pomerleau CS, Pomerleau OF (1997). Do men and women differ in exposure per cigarette? Tobacco Control 6:61. 79. Pomerleau OF, Pomerleau CS, Namenek RJ (1998). Early experiences with nicotine among women smokers, ex-smokers, and never-smokers. Addiction 93:595-599. 80. Pomerleau OF (1998) Endogenous opioids and smoking: A review of progress and problems. Psychoneuroendocrinology 23:115-130. 81. Marks JL, Pomerleau CS, Pomerleau OF (1999). Effects of menstrual phase on reactivity to nicotine. Addictive Behaviors 24:127-134. 82. Pomerleau OF, Kardia SLR (1999). Health psychology and genetic research on smoking (invited commentary). Health Psychology 18:3-6. 83. Pomerleau CS, Pomerleau OF, Namenek RJ, Marks JL (1999). Initial exposure to nicotine in college-age women smokers and never-smokers: A replication and extension. Journal of Addictive Diseases 8:13-19. 84. Dalack GW, Becks L, Hill E, Pomerleau OF, Meador-Woodruff JH (1999). Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia. Neuropsychopharmacology 21:195-202. 85. Pomerleau CS, Pomerleau OF, Namenek RJ, Mehringer AM (2000). Short-term weight gain in abstaining women smokers. Journal of Substance Abuse Treatment 18: 339-342. 86. Pomerleau CS, Mehringer AM, Marks JL, Downey KK, Pomerleau OF (2000). Effects of menstrual phase and smoking abstinence in smokers with and without a history of Major Depressive Disorder. Addictive Behaviors 25:483-497. 87. Pomerleau OF, Pomerleau CS, Marks JL (2000). Abstinence effects and reactivity to nicotine during eleven days of smoking deprivation. Nicotine & Tobacco Research 2:149-157. 88. Pomerleau CS, Marks JL, Pomerleau OF (2000). Who gets what symptom? Effects of psychiatric cofactors and nicotine dependence on patterns of nicotine withdrawal symptomatology. Nicotine & Tobacco Research 2:275-280. 89. Pomerleau CS, Namenek Brouwer, R.J., Pomerleau OF (2001). Emergence of depression during early abstinence in depressed and non-depressed women smokers. Journal of Addictive Diseases 20:73-80. 90. Pomerleau CS, Zucker AN, Namenek Brouwer, R.J., Pomerleau OF, Stewart, A.J. (2001). Race differences in weight concerns among women smokers: Results from two independent samples. Addictive Behaviors 26:651-663. 91. Trask PC, Schwartz SM, Deaner SL, Paterson AG, Johnson T, Rubenfire M, Pomerleau OF (2002). Behavioral Medicine: The challenge of integrating psychological and behavioral approaches into Primary Care. Effective Clinical Practice, 5:75-83. 92. Pomerleau OF, Pomerleau CS, Marks JL, Snedecor SM, Mehringer AM, Namenek Brouwer, R.J., Saules KK (2003). Prolonged nicotine patch use in quitters with past abstinence-induced depression. Journal of Substance Abuse Treatment, 24, 13-18. 93. Pomerleau CS, Downey KK, Snedecor SM, Mehringer AM, Marks JL, Pomerleau OF (2003). Smoking patterns and abstinence effects in smokers with no ADHD, childhood ADHD, and adult ADHD symptomatology. Addictive Behaviors 28, 1149-1157. 94. Marks JL, Swan, G., Pomerleau CS, Pomerleau OF (2003). Agreement between proband and parental self-report of smoking behavior. Nicotine & Tobacco Research 5;527-533. 95. Benowitz NL, Pomerleau OF, Pomerleau CS, Jacob P III (2003). Nicotine metabolite ratio as a predictor of cigarette consumption. Nicotine & Tobacco Research 5:621-624. 96. Pomerleau OF, Fagerstrom K-O, Marks JL, Tate JC, Pomerleau CS (2003). Development and validation of a scale for assessing positive- and negative-reinforcement smoking: The Michigan Nicotine Reinforcement Questionnaire. Nicotine & Tobacco Research 5, 711-718. 97. Pomerleau OF, Hughes JR (2004). With a little help from its friends: A brief history of the Society for Research on Nicotine and Tobacco. Nicotine & Tobacco Research 6:391-395. 98. Pomerleau CS, Pomerleau OF, Snedecor SM, Mehringer AM (2004). Defining a never-smoker: Results from the Nonsmokers Survey. Addictive Behaviors 29:1149-1154. 99. Pomerleau CS, Marks JL, Pomerleau OF, Snedecor SM (2004). Relationship between early experiences with tobacco and early experiences with alcohol. Addictive Behaviors 29:1245-1251. 100. Pomerleau OF, Pomerleau CS, Snedecor SM, Gaulrapp S, Brouwer RN, Cameron OG (2004). Depression, smoking abstinence, and HPA function in women smokers. Human Psychopharmacology: Clinical & Experimental 19:467-476. 101. Pomerleau CS, Pomerleau OF, Snedecor SM, Gaulrapp S, Kardia SLR (2004). Heterogeneity in phenotypes based on smoking status in the Great Lakes Smoker Sibling Registry. Addictive Behaviors 29:1851-1855. 102. Pomerleau CS, Snedecor, S., Ninowski R, Gaulrapp S, Pomerleau OF, Kardia SLR (2005). Differences in accuracy of offspring assessment based on parental smoking status. Addictive Behaviors 3: 437-441. 103. Pomerleau OF, Pomerleau CS, Mehringer AM, Snedecor SM, Cameron OG (2005). Validation of retrospective reports of early experiences with smoking. Addictive Behaviors 30:607-611. 104. Pomerleau OF, Pomerleau CS, Mehringer AM, Snedecor SM, Ninowski R, Sen A. (2005). Nicotine dependence, depression, and gender: Characterizing phenotypes based on withdrawal discomfort, response to smoking, and ability to abstain. Nicotine & Tobacco Research 7:91-102. 105. Karam-Hage M, Pomerleau CS, Pomerleau OF, Brower KJ (2005). Unaided smoking cessation at six-month follow-up in smokers in treatment for alcohol dependence. Addictive Behaviors 30:1247-1253. 106. Snedecor SM, Pomerleau CS, Mehringer AM, Ninowski R, Pomerleau OF (2006). Differences in smoking-related variables based on phenylthiocarbamide “taster” status. Addictive Behaviors, 39:2301-2312. 107. Pomerleau OF, Pomerleau CS, Chu J, Kardia SLR (2007). Genome-wide linkage analysis for smoking-related genomic regions with replication in two ethnically diverse populations. Nicotine & Tobacco Research 9:955-958. 108. Pomerleau OF, Burmeister M, Madden P, Long J, Swan GE, Kardia SLR (2007). Genetic research on complex behaviors: An examination of attempts to identify genes for smoking. Nicotine & Tobacco Research 9:883-901 109. Bierut LJ, Madden PA, Breslau N, Johnson EO, Hatsukami D, Pomerleau OF, Swan GE, Rutter J, Bertelsen S, Fox L, Fugman D, Goate AM, Hinrichs AL, Konvicka K, Martin NG, Montgomery GW, Saccone NL, Saccone SF, Wang JC, Chase GA, Rice JP, Ballinger DG (2007). Novel genes identified in a high density genome wide association study for nicotine dependence. Human Molecular Genetics 16(1):24-35. [Epub ahead of print 12/7/2006] 110. Saccone SF, Hinrichs AL, Saccone NL, Chase GA, Konvicka K, Madden PA, Breslau N, Johnson EO, Hatsukami D, Pomerleau OF, Swan GE, Goate AM, Rutter J, Bertelsen S, Fox L, Fugman D, Martin NG, Montgomery GW, Wang JC, Ballinger DG, Rice JP, Bierut LJ (2007). Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study Targeting 348 Candidate Genes with 3,713 SNPs. Human Molecular Genetics 16:36-49. [Epub ahead of print 11/29/06] 111. Strecher VJ, McClure J, Alexander G, Nair V, Konkel J, Greene S, Collins L, Carlier C, Wiese C, Chakraborty B., Little R, Pomerleau CS, Pomerleau OF (2008). Web-based smoking cessation components and tailoring depth: Results of a randomized trial. American Journal of Preventive Medicine 34:373-381. 112. Ríos-Bedoya CF, Snedecor SM, Pomerleau CS, Pomerleau OF (2008). Association of withdrawal features with nicotine dependence as measured by the Fagerström Test for Nicotine Dependence (FTND). Addictive Behaviors 33:1086-1089. 113. Sherva R, Wilhelmsen K, Pomerleau CS, Chasse SA, Rice JP, Snedecor SM, Bierut LJ, Neuman RJ, Pomerleau OF (2008). Association of a SNP in neuronal acetylcholine receptor subunit alpha 5 (CHRNA5) with positive experience ("pleasurable buzz") during initial smoking. Addiction 103:1544-1552. 114. Bierut LJ, Stitzel JA, Wang JC, Hinrichs AL, Bertelsen S, Fox L, Grucza RA, Horton WJ, Kauwe JS, Morgan SD, Saccone NL, Saccone SF, Suei X, Breslau N, Budde J, Chase GA, Cloninger CR, Dick DM, Foroud T, Hatsukami D, Hesselbrock V, Johnson EO, Kramer J, Kuperman S, Madden PAF, Mayo K, Maxwell T, Nurnberger J, Pomerleau OF, Porjesz B, Reyes O, Schuckit M, Swan G, Tischfield JA, Edenberg HJ, Rice JP, Goate AM (2008). Variants in the nicotinic receptors alter the risk for nicotine dependence. American Journal of Psychiatry, 165:1163-1171. 115. Strecher VJ, McClure J, Alexander G, Nair V, Konkel J, Greene S, Couper M, Carlier C, Wiese C, Chakraborty B., Little R, Pomerleau CS, Pomerleau OF (2008). The role of engagement in a tailored web-based smoking cessation program: Results of a randomized trial. Journal of Medical Internet Research, Nov. 4, 10(5):e36. 116. Ríos-Bedoya CF, Pomerleau CS, Neuman RJ, Pomerleau OF (2009). Using MIMIC models to examine the relationship between current smoking and early smoking experiences. Nicotine & Tobacco Research 11:1035-1041. 117. Pomerleau OF, Pomerleau CS, Snedecor SM, Finkenauer R, Mehringer AM, Langenecker SA, Sirevaag EJ (2009). Substance use, trait measures, and subjective response to nicotine in never-smokers stratified on parental smoking history and sex. Nicotine & Tobacco Resarch 11:1055-1066.. 118. Finkenauer R, Pomerleau CS, Snedecor SM, Pomerleau OF (2009). Race differences in factors related to smoking initiation. Addictive Behaviors 34:1056-1059. 119. Pomerleau CS, Snedecor SM, Pomerleau OF (2009). Never-smokers with a positive family smoking history are more likely to be overweight or obese than never-smokers with a negative family smoking history. Eating Behaviors, 10:49-51. 120. Pomerleau OF, Pomerleau CS (2011). Commentary on Haberstick et al. (2011), Dizziness upon initial experimentation with cigarettes - implications for smoking persistence. Addiction 106:400-401. 121. Wang S, van der Vaart AD, Xu Q, Seneviratne C, Pomerleau OF, Pomerleau CS, Payne TJ, Ma JZ, Li MD (2014). Significant association of CHRNA2 and CHRNA6 with nicotine dependence in European American and African American populations. Human Genetics, 133:292-310. 122. Balfour DJK, Benowitz NL, Colby SM, Hatsukami DK, Lando HA, Leischow SJ, Lerman C, Mermelstein RJ, Niaura R, Perkins KA, Pomerleau OF, Rigotti NA, Swan GE, Warner KE, West R (2021). Balancing consideration of the risks and benefits of e-cigarettes. American Journal of Public Health 111:1661-1672. https://doi.org/10.2105/AJPH.2021.306416.
Non-Peer-Reviewed Publications 1. Pertschuk M, Pomerleau OF (1975). Behavior modification in preventive medicine (Letter to the Editor). New England Journal of Medicine 292:310. 2. Pomerleau OF, Brady JP (1975). Behavior modification in medical practice, with an example from the treatment of problem drinking. Pennsylvania Medicine 78:49-53. 3. Pomerleau OF (1976). You can get patients to change their habits. Medical Times, October, 149-158. 4. Pomerleau OF (1976). Review of W.E. Fordyce, Behavioral Methods for Chronic Pain and Illness (St. Louis: C.V. Mosby, 1976). New England Journal of MedicinE 294:1352. 5. Pomerleau OF (1977). Review of P.M. Miller, M.A. Mastria, Alternatives to Alcohol Abuse: A Social Learning Model (Champaign, Illinois: Research Press, 1977). Behavior Therapy and Experimental Psychiatry 8:453. 6. Pomerleau OF (1978). On behaviorism in behavioral medicine (invited editorial). Behavioral Medicine Newsletter 1:2. 7. Pomerleau OF (1983). A short response to Williams' review of Break the Smoking Habit. Behavior Therapist 6:90. 8. Pomerleau OF (1984). Review of J.E. Smith, J.D. Lane, (Eds.), The neurobiology of opiate reward processes (Amsterdam: Elsevier Biomedical Press, 1983). The Quarterly Review of Biology 59:203. 9. Pomerleau CS, Pomerleau OF (1984). Neuroregulators and smoking: New hope for smokers who want to quit. Healthline 3(8):10-11. 10. Pomerleau OF (1986). Addiction: A house divided. Review of Peele, S., The meaning of addiction: Compulsive experience and its interpretation (Lexington, MA: D.C. Heath and Company, 1985). Contemporary Psychology 31:505-506. 11. Pomerleau OF et al. (1986). NHLBI Task Force on Relapse Prevention: Nicotine and smoking relapse. Health Psychology 5:41-51. 12. Pomerleau OF, Pomerleau CS (1987). La dependance tabagique: Explication biocomportementale. La Semaine des Hôpitaux 63:3345-3354. 13. Pomerleau OF, Pomerleau CS (1988). On observing the unobservable, Commentary on Integrating research on self-control, by Logue AW. Behavioral and Brain Sciences 11:692. 14. Pomerleau OF (1988). Observations on the role of human experimentation in understanding and managing drug abuse. Psychopharmacology Newsletter 21(4):4-5. 15. Pomerleau OF (1992). Nicotine and the central nervous system: Biobehavioral effects of cigarette smoking. In Lesmes, G.R. (Ed.), Proceedings of a Symposium: The effects of cigarette smoking: A global perspective. The American Journal of Medicine 93 (1A July 15):2S - 7S. 16. Pomerleau OF, Pomerleau CS (1992). La nicotine, le cortisol, et le stress. La Semaine des Hôpitaux 68:1259-1269. 17. Pomerleau OF (1994). FDA hearings on nicotine abuse liability and addiciton. Society for Research on Nicotine and Tobacco Newsletter 1(1):2,10. 18. Pomerleau OF (1995). Review of Christopher Buckley, Thank you for smoking (New York: Random House, 1994). Society for Research on Nicotine and Tobacco Newsletter 1(2):4. 19. Pomerleau OF (1996). Future of nicotine research: View from the top. Society for Research on Nicotine and Tobacco Newsletter 2(2):3,6. 20. Perkins KA, Benowitz N, Henningfield J, Newhouse P, Pomerleau OF, Swan GE (1996). Conference Summary: Society for Research on Nicotine and Tobacco. Addiction 91:129-144. 21. Pomerleau OF (1996). Eclipse and related tobacco products. The Addictions Newsletter 4(1):8. 22. Pomerleau OF (1997) Nicotine et troubles neurodégénératifs. In Aubin H-J (Ed.), Nicotine et troubles neuropsychiatriques (pp. 47-57). Paris, France: Masson. 23. Swan GE, Balfour DJK, Pomerleau OF (1999). Nicotine & Tobacco Research: A forum for science-based results (editorial). Nicotine & Tobacco Research 1:5-7. 24. Berrettini W, Bierut L, Crowley TJ, Cubells JF, Frascella J, Gelernter J, Hewitt JK, Kreek MJ, Lachman H, Leppert M, Li MD, Madden P, Miner C, Pollock JD, Pomerleau OF, Rice JP, Rutter JL, Shurtleff D, Swan GE, Tischfield JA, Tsuang M, Uhl GR, Vanyukov M, Volkow ND, Wanke K (2004). Setting priorities for genomic research (Letter to the Editor). Science 304:1445-1447. 25. Balfour et al. Respond (2022): Balfour DJK, Benowitz NL, Colby SM, Hatsukami DK, Lando HA, Leischow SJ, Lerman C, Mermelstein RJ, Niaura R, Perkins KA, Pomerleau OF, Rigotti NA, Swan GE, Warner KE, West R. American Journal of Public Health. 2022 Jan;112(1):e5-e6. doi: 10.2105/AJPH.2021.306570.PMID: 34936414 26. Balfour et al. Respond (2022): Balfour DJK, Benowitz NL, Colby SM, Hatsukami DK, Lando HA, Leischow SJ, Lerman C, Mermelstein RJ, Niaura R, Perkins KA, Pomerleau OF, Rigotti NA, Swan GE, Warner KE, West R. American Journal of Public Health. 2022 Jan;112(1):e2-e3. doi: 10.2105/AJPH.2021.306555.PMID: 34936419
Books 1. Pomerleau OF, Pomerleau CS (1977). Break the Smoking Habit: A Behavioral Program for Giving Up Cigarettes. Champaign, Illinois: Research Press. Reissued, West Hartford, Connecticut: Behavioral Medicine Press, 1984. Spanish edition: T. Segur (translator). Como Dejar de Fumar. Barcelona: Bruguera, 1980. 2. Pomerleau OF, Brady JP (Eds.) (1979). Behavioral Medicine: Theory and Practice. Baltimore: Williams, Wilkins. 3. Pomerleau OF, Pomerleau CS (Eds.) (1988). Nicotine Replacement: A Critical Evaluation. New York, NY: Alan R. Liss, Inc.; Reissued (1992) Binghamton NY: Haworth Press.
Journals Edited 1. Pomerleau OF (Ed.) (1983). Forum on Employee Health and Fitness. Preventive Medicine, 12:597-681. 2. Pomerleau OF, Pomerleau CS (Eds.) (1989). Nicotine uses and abuses: From brain probe to public health menace. Journal of Substance Abuse 1:253-368. Chapters in Books 1. Pomerleau OF (1976). Some suggestions for research in the smoking-cessation clinic. In Steinfeld J et al. (Eds.), "Smoking and Health, II: Health Consequences, Education, Cessation Activities and Social Action," Proceedings of the Third World Conference on Smoking and Health (pp. 643-648). Washington, D.C.: U.S. Government Printing Office. 2. Pomerleau OF, Mack R (1976). Behavior modification in pediatric practice. In Haggerty RJ, Green M (Eds.), Ambulatory Pediatrics II (pp. 454-460). Philadelphia: W.B. Saunders Co. 3. Pomerleau OF (1976). Controlled drinking as a treatment goal for the alcoholic: Current perspectives. In Brady JP, Mendels J, Orne MT, Reiger W (Eds.), Psychiatry: Areas of Promise and Advancement (pp. 205-216). New York: Spectrum Publications, Inc. 4. Pomerleau OF, Pertschuk M, Adkins D, d'Aquili E (1978) Treatment for middle income problem drinkers. In Nathan P, Marlatt A (Eds.), Alcoholism: New Directions in Behavioral Research and Treatment (pp. 143-160). New York: Plenum Press. 5. Pomerleau OF (1978). Strategies for maintenance: The problem of sustaining abstinence from cigarettes. In Schwartz J (Ed.), Progress in Smoking Cessation (pp. 355-364). New York: American Cancer Society. 6. Pomerleau OF, Brady JP (1979). Introduction: The scope and promise of behavioral medicine. In Pomerleau OF, Brady JP (Eds.), Behavioral Medicine: Theory and Practice (pp. xi-xxvi). Baltimore, MD: Williams, Wilkins. 7. Pomerleau OF (1979). Behavioral factors in the establishment, maintenance, and cessation of smoking. In Surgeon General's Report on Smoking and Health (pp. 16/3-24). Washington, D.C.: U.S. Government Printing Office. 8. Pomerleau OF (1979). Commonalities in the treatment and understanding of smoking and other self-management disorders. In Krasnegor N (Ed.), Behavioral Analysis and Treatment of Substance Abuse (NIDA Research Monograph #25) (pp. 140-156). Rockville, Maryland: National Institute on Drug Abuse. 9. Pomerleau OF (1979). Behavioral factors in the establishment, maintenance, and cessation of smoking. In Krasnegor N (Ed.), The Behavioral Aspects of Smoking (NIDA Research Monograph #26) (pp. 47-67). Rockville, Maryland: National Institute on Drug Abuse. 10. Pomerleau OF (1980). Why people smoke: Current psychobiological theories. In Davidson P (Ed.), Behavioral Medicine: Changing Health Lifestyles (pp. 94-115). New York: Brunner/Mazel. 11. Pomerleau OF, Adkins D (1980). Evaluating behavioral and traditional treatment for problem drinkers. In Sobell L, Sobell M, Ward E (Eds.), Evaluating Alcohol and Drug Abuse Treatment Effectiveness (pp. 52-108). New York: Pergamon Press. 12. Pomerleau OF (1982). Current behavioral therapies in the treatment of alcoholism. In Pattison M, Kaufman E (Eds.), Encyclopedic Handbook of Alcoholism (pp. 1054-1067). New York: Gardner Press. 13. Pomerleau OF, Kadden RM (1983). Behavioral treatment of the employed alcohol abuser: Techniques for moderation and abstinence. In Manuso J (Ed.), Handbook of Occupational Clinical Psychology (pp. 55- 69). New York: Praeger. 14. Cooney N, Baker L, Pomerleau OF (1983). Cue exposure for relapse prevention in alcohol treatment. In McMahon R, Craig K (Ed.), Advances in Clinical Behavior Therapy (pp. 194-210). New York: Brunner/Mazel. 15. Kadden R, Pomerleau OF, Meyer RE (1984). On the stimulus control of drinking in alcoholics. In Harris LS (Ed.), Problems in Drug Dependence (NIDA Research Monograph #49). Rockville, Maryland: National Institute on Drug Abuse. 16. Pomerleau OF, Rodin J (1986). Behavioral medicine and health psychology. In Garfield SL, Bergin AE (Eds.), Handbook of Psychotherapy and Behavior Change (3rd ed.) (pp. 483-522). New York: John Wiley, Sons. 17. Pomerleau OF (1986). The "why" of tobacco dependence: Underlying reinforcing mechanisms in nicotine self-administration. In Ockene JK (Ed.), Pharmacologic Treatment of Tobacco Dependence: Proceedings of the World Congress (pp. 32-47). Cambridge, MA: Institute for the Study of Smoking Behavior and Policy. 18. Baker LH, Cooney NL, Pomerleau OF (1987). Craving for alcohol: Theoretical considerations and treatment procedures. In Cox WM (Ed.), Treatment and Prevention of Alcohol Problems: Resource Manual (pp. 183-202). New York: Academic Press. 19. Pomerleau OF, Pomerleau CS (1987). A biobehavioral view of substance abuse and addiction. In Peele S (Ed.), Visions of addiction (pp. 117-139). Lexington, Massachusetts: Lexington Books. 20. Pomerleau OF, Pomerleau CS (1988). Introduction. In Pomerleau OF, Pomerleau CS (Eds.), Nicotine Replacement: A Critical Evaluation (pp. 1-9). New York, NY: Alan R. Liss, Inc. 21. Pomerleau OF, Pomerleau CS (1988). Overview. In Pomerleau OF, Pomerleau CS (Eds.), Nicotine Replacement: A Critical Evaluation (pp. 279-295). New York, NY: Alan R. Liss, Inc. 22. Pomerleau OF, Pomerleau CS (1988). Neuroendocrine response to nicotine in cigarette smokers. In Rand MJ, Thurau K (Eds.), International Symposium on Nicotine (pp. 321-335). Miami, FL: ICSU Press. 23. Pomerleau OF, Pomerleau CS (1989). A biobehavioral perspective on smoking. In Ney T, Gale A (Eds.), Smoking and Human Behavior (pp. 69-90). Chichester, England: John Wiley and Sons. 24. Pomerleau OF, Pomerleau CS (1990). Biobehavioral studies in humans: Anxiety, stress, and smoking. In Bock G, Marsh J (Eds.), The Biology of Nicotine Dependence (CIBA Foundation Symposium No. 152, pp. 225-239). Chichester: John Wiley, Sons Ltd. 25. Greden JF, Pomerleau OF (1995). Caffeine-related disorders and nicotine-related disorders. In Kaplan HI, Sadock BJ (Eds.), Comprehensive Textbook of Psychiatry/VI (pp. 799-810). Baltimore: Williams, Wilkins. 26. Pomerleau OF (1995). Neurobiological interactions of alcohol and nicotine. In Fertig JB, Allen J (Eds.), Alcohol and Tobacco: From Basic Science to Clinical Practice (NIAAA Research Monograph #30) (pp. 145-158). Bethesda, Maryland: National Institute on Alcohol Abuse and Alcoholism. 27. Smith M, Pomerleau OF, Wadland W (1997). Nicotine and Smoking: A guide to the management of behavioral health problems in the primary care setting. In Knesper D, Riba M, Schwenk T (Eds.), Primary Care Psychiatry. Philadelphia: WB Saunders Company. 28. Pomerleau OF (1997). Nicotine dependence. In Bolliger, C.T., Fagerstrom, K.-O. (Eds.), Progress in Respiration Research: The Tobacco Epidemic. (vol 28, pp. 122-131) Basel: S. Karger. 29. Pomerleau OF, Aubin H-J, Pomerleau CS (1998). Un etat anxio-dépressif, la crainte d’une prise de poids, ou la consommation excessive d’alcool influencent-ils les modalités de l’aide à l’arrêt de la consommation de tabac? In L’arrêt de la consommation de tabac: Conférence de consensus (pp. 130-137). Paris, France: Éditions E.D.K.
Abstracts 1. Pomerleau OF (1970). The effects of cued, response-independent shocks on shock-avoidance behavior in the rhesus monkey (Doctoral dissertation, Columbia University, 1969), Dissertation Abstracts. Ann Arbor, MI: University Microfilms. 2. Pertschuk M, Pomerleau OF, Brady JP, Edwards N (1975). Preliminary report on a behavioral treatment for problem drinking. Psychosomatic Medicine 37:93. 3. Seyler LE, Fertig JB, Pomerleau OF, Parker K, Hunt D (1981). Neurophysin I release during cigarette smoking correlates with nausea and not with nicotine dose. Clinical Research 29:666A. 4. Fertig JB, Seyler LE, Pomerleau OF, Hunt D, Parker K (1982). Release of five human pituitary hormones during smoking correlates with nausea and not nicotine. Clinical Research 30:270A. 5. Pomerleau OF (1984). Reinforcing properties of nicotine: Smoking-induced vasopressin and beta-endorphin release, antinociception and anxiety reduction. Pavlovian Journal of Biological Science 19:107. 6. Meyer RE, Pomerleau OF (1985). Alcohol dependence: A biobehavioral perspective. Proceedings of the IVth World Conference of Biological Psychiatry. 7. Pomerleau CS, Pomerleau OF (1986). Performance anxiety, smoking, and cardiovascular reactivity. Psychosomatic Medicine, 48:300. 8. Pomerleau CS, Pomerleau OF, Majchrzak MJ, Hajjar J-J, Shanahan WR (1986). Effects of mecamylamine on subsequent smoking and plasma nicotine. Pharmacology, Biochemistry & Behavior 25:311. 9. Pomerleau OF, Pomerleau CS, Majchrzak MJ (1986). Pituitary hormone response to nicotine in cigarette smokers. Pharmacology, Biochemistry & Behavior 25:312. 10. Majchrzak MJ, Pomerleau OF, Pomerleau CS (1987). Nausea, cigarette smoking, nicotine, and pituitary hormone release. In Martin, W.K., van Loon, G.R., Iwamoto, E.T., Davis, D.L. (Eds.), Tobacco Smoking and Nicotine: A Neurobiological Approach (p. 301). New York: Plenum Publishing Company. 11. Henningfield, J.E., Pomerleau OF (1987). Pharmacologic and neuroendocrine basis of nicotine replacement. Pharmacology, Biochemistry & Behavior 27:602. 12. Morrell, E.M., Pomerleau CS, Majchrzak MJ, Pomerleau OF, Malakuti, R. (1988). Heart-rate elevations in Type A women: A community-based sample. Psychosomatic Medicine 50:201. 13. Pomerleau OF (1988). Integration of behavioral and biological factors in smoking: A peek inside the black box. Pharmacology, Biochemistry & Behavior 29:656. 14. Pomerleau OF, Pomerleau CS (1989). Nicotine, stress, and corticosteroid activity. Pharmacology, Biochemistry & Behavior 32:1095. 15. Pomerleau OF, Pomerleau CS, Morrell, E.M., Lowenbergh, J.M. (1990). Effects of fluoxetine upon weight gain and food intake in smokers with reduced nicotine intake. NeuroEndocrinology Letters, 12: 312. 16. Pomerleau CS, Garcia AW, Pomerleau OF, Cameron OG (1991). Effects of menstrual phase and nicotine withdrawal on plasma MHPG in smokers. Biological Psychiatry, 29:154A. 17. Pomerleau OF, Spring B, Pomerleau CS (1992). Serotonergic agents modulate weight gain following smoking cessation. Problems of Drug Dependence: Proceedings of the 53rd Annual Scientific Meeting, Committee on Problems of Drug Dependence, Inc. (NIDA Research Monograph 119, USDHHS), p. 469. 18. Pomerleau OF, Pomerleau CS, Cameron OG, Hariharan M (1993). Sensitivity to nicotine in smokers and never-smokers. Problems of Drug Dependence: Proceedings of the 54th Annual Scientific Meeting, Committee on Problems of Drug Dependence, Inc. (NIDA Research Monograph, USDHHS), p. 349. 19. Garcia AW, Pomerleau OF, Pomerleau CS, Drewnowski A (1993). Effects of fluoxetine and taste preference on weight loss in obese women. Annals of Behavioral Medicine 15:S40. 20. Lumley MA, Hess PM, Pomerleau OF (1993) Alexithymia, smoking, and nicotine. Psychosomatic Medicine 55:107. 21. Pomerleau CS, Pomerleau OF (1994). Depression as a smoking withdrawal symptom. Annals of Behavioral Medicine 16:S117. 22. Pomerleau CS, Pomerleau OF (1994). Gender differences in frequency of smoking withdrawal symptoms. Annals of Behavioral Medicine 16:S118. 23. Pomerleau CS, Downey KK, Stelson FW, Pomerleau OF (1994). Smoking and adult ADHD: A connection? Journal of Addictive Diseases 13:242. 24. Pomerleau CS, Kurth CL, Pomerleau OF (1994). An association between binge-eating and "weight-control" smoking in women smokers. Journal of Smoking-Related Disorders, 5(1):326 25. Pomerleau OF (1995). Nicotine et pathologie neurodégénérative. Alcoologie, 17:234. 26. Scherzer H, Judge J, Grunberg N, Pomerleau CS, Pomerleau OF (1995). The catecholamines and endorphin stress response to inspiratory muscle loading during light exercise. American Journal of Respiratory Disease and Critical Care Medicine 151(4):A805. 27. Pomerleau CS, Pomerleau OF, Downey KK, Mehringer AM (1996). A test to predict depression as a smoking withdrawal symptom. Addiction 91(1):142-143. 28. Dalack GW, Becks L, Hill E, Pomerleau OF, Meador-Woodruff JH (1996) Nicotine withdrawal and psychiatric symptoms in smokers with schizophrenia. Biological Psychiatry 39:547. 29. Pomerleau CS, Marks JL, Pomerleau OF (1998). Childhood ADHD symptomatology in a sample of smokers: A descriptive study. Journal of Addictive Diseases 17:137. 30. Marks JL, Pomerleau CS, Pomerleau OF (1999). Relationship between FTQ and DSM-III-R criteria for nicotine dependence. Nicotine & Tobacco Research 1:106. 31. Pomerleau OF, Pomerleau CS (1999). Initial exposure to nicotine in college-age women smokers and never-smokers. Nicotine & Tobacco Research 1:109. 32. Downey KK, Pomerleau OF, Shiffman S, Leischow S, Pomerleau CS, Marks JL (2000). Morning versus evening nicotine craving and withdrawal symptoms: a descriptive profile and relation to Fagerstrom tolerance questionnaire scores. Nicotine & Tobacco Research 2:292. 33. Pallonen, U.E., Pomerleau CS, Pomerleau OF, Williams D (2002). Effects of early smoking experiences on adolescent smoking behavior. Nicotine & Tobacco Research 4:377.
Audiovisual Educational Materials 1. Pomerleau OF, Pomerleau CS, Weinstein HS (1976). Success Over Smoking (SOS), a professionally-supervised self-help smoking-cessation program (cassette). Washington, D.C.: Educational Services, Inc. 2. Pomerleau OF (1977). Deep-muscle relaxation procedure (cassette). Washington, D.C.: Educational Services, Inc. 3. Pomerleau OF (1982). Symposium on research on underlying mechanisms in self-management and substance abuse (Cassette 38-10-82). New York: Audio-Video Transcripts. 4. Pomerleau OF (1987). S.O.S.: Success Over Smoking (Psychology Today tape #20324). Washington, D.C.: American Psychological Association. 5. Pomerleau OF (1994). Scientific Consultant, Patch Plus: Smoking Cessation Program. Guelph, Ontario, Canada: Homewood Services, Inc. 6. Pomerleau OF How to protect yourself from the new employment contract. Commentary, WUOM Public Radio, June, 1996. 7. Pomerleau OF Critique of substance abuse policy. Commentary, WUOM Public Radio, April, 1997. 8. Pomerleau OFDon’t stop smoking now. Commentary, WUOM Public Radio, May, 1997.
